Clinical Utility of Universal Broad-Range Polymerase Chain Reaction Amplicon Sequencing for Pathogen Identification: A Retrospective Cohort Study
- PMID: 31907545
- PMCID: PMC7486847
- DOI: 10.1093/cid/ciz1245
Clinical Utility of Universal Broad-Range Polymerase Chain Reaction Amplicon Sequencing for Pathogen Identification: A Retrospective Cohort Study
Abstract
We assessed the real-world utility of universal broad-range polymerase chain reaction sequencing for pathogen detection. Among 1062 clinical samples, 107/1062 (10.1%) had a clinically significant, positive result, with substantial variation by specimen type. Clinical management was changed in 44/1062 (4.1%). These data can help maximize utility of this emerging diagnostic.
Keywords: DNA sequencing; broad-range universal PCR; molecular diagnostics; pathogen identification.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
A Laboratory's Guide to the Universe of Broad-Range Polymerase Chain Reactions.Clin Infect Dis. 2020 Sep 12;71(6):1558-1560. doi: 10.1093/cid/ciz1246. Clin Infect Dis. 2020. PMID: 31907533 No abstract available.
References
-
- Rampini SK, Bloemberg GV, Keller PM, et al. Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. Clin Infect Dis 2011; 53:1245–51. - PubMed
-
- Han XY, Pham AS, Tarrand JJ, Sood PK, Luthra R. Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. Am J Clin Pathol 2002; 118:796–801. - PubMed
